Edition:
United States

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

5.37USD
26 Apr 2018
Change (% chg)

$-0.01 (-0.19%)
Prev Close
$5.38
Open
$5.39
Day's High
$5.45
Day's Low
$5.34
Volume
58,338
Avg. Vol
171,594
52-wk High
$8.17
52-wk Low
$4.41

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.04 0.10 0.00 --
Quarter Ending Sep-18 4 0.04 0.10 0.00 --
Year Ending Dec-18 5 0.18 0.40 0.12 3.88
Year Ending Dec-19 7 2.27 15.18 0.00 35.43
Earnings (per share)
Quarter Ending Jun-18 4 -0.16 -0.12 -0.19 --
Quarter Ending Sep-18 4 -0.19 -0.16 -0.21 --
Year Ending Dec-18 5 -0.67 -0.56 -0.79 -0.44
Year Ending Dec-19 6 -0.62 -0.19 -0.93 -0.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.16 45.72
P/E Low - Last 5 Yrs. -- 91.58 24.22
Beta -- 0.90 0.88
Price to Sales (TTM) -- 110.88 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) -- 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions -- 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.71 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.06 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) -- 5.30 2.98
LT Debt to Equity (MRQ) -- 22.96 12.18
Total Debt to Equity (MRQ) -- 24.62 16.45
Interest Coverage (TTM) -- -99.34 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.72 10.96
Operating Margin (TTM) -- -718.49 4.73
Operating Margin - 5 Yr. Avg. -- -596.03 6.40
Pre-Tax Margin (TTM) -- -692.96 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.39 6.81
Net Profit Margin (TTM) -- -694.19 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.24 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,625,667 846,829,796
Net Income/Employee (TTM) -- 2,971,219 99,616,056
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) -- 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.11 10.95
Return on Assets - 5 Yr. Avg. -- -0.57 12.31
Return on Investment (TTM) -- 1.58 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.10
Return on Equity (TTM) -- 2.41 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.